This Biotech Stock 355% Breakout: Deep Track Bets Big
A biotech stock has surged 355%, catching the eye of every investor from day traders to pension funds. A prominent he...
A ten-year comparison of Aristocrats ETFs highlights performance patterns, dividend consistency, and growth trajectory to aid selection.
27,377 articlesA biotech stock has surged 355%, catching the eye of every investor from day traders to pension funds. A prominent he...
A Mt. Gox-linked wallet moved 10,306 BTC valued at roughly $731 million to a new address, triggering market chatter a...
SpaceX is not publicly traded, but exposure can hide in retirement funds. Analysts say large mutual funds and 401(k) ...
A man inherits his mother’s home and avoids a six-figure capital gains tax thanks to the stepped-up basis. The rule r...
Global worker engagement remains stuck near crisis levels, even as AI and remote work reshape the office. This story ...
Geopolitical turmoil and potential chokepoint disruptions raise the odds of a renewed oil shock. Markets bracing $100...
Mission Produce enters 2026 with a mix of hedges, growing demand, and a tight supply chain. This guide breaks down wh...
A high-profile Tampa real estate group is back with eXp Realty, rebranding as FIG Team Maximum Tampa and expanding it...
Sumitomo Forestry has completed its $4.5 billion acquisition of Tri Pointe Homes, moving the combined group into the ...
Affordability for homebuyers improved in April as the 30-year rate slipped to 6.33%, lifting the Housing Affordabilit...
A fresh look at a chilling historical echo: the 1987 omen: kevin warsh's. As markets brace for a new Fed chair, inves...
Medicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...